81 related articles for article (PubMed ID: 8164885)
1. Toxicology of baclofen continuously infused into the spinal intrathecal space of the dog.
Sabbe MB; Grafe MR; Pfeifer BL; Mirzai TH; Yaksh TL
Neurotoxicology; 1993; 14(4):397-410. PubMed ID: 8164885
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal ketorolac in dogs and rats.
Yaksh TL; Horais KA; Tozier N; Rathbun M; Richter P; Rossi S; Grafe M; Tong C; Meschter C; Cline JM; Eisenach J
Toxicol Sci; 2004 Aug; 80(2):322-34. PubMed ID: 15141096
[TBL] [Abstract][Full Text] [Related]
3. Studies on the safety of chronically administered intrathecal neostigmine methylsulfate in rats and dogs.
Yaksh TL; Grafe MR; Malkmus S; Rathbun ML; Eisenach JC
Anesthesiology; 1995 Feb; 82(2):412-27. PubMed ID: 7856900
[TBL] [Abstract][Full Text] [Related]
4. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
[TBL] [Abstract][Full Text] [Related]
5. Development of baclofen tolerance in a rat model of chronic spasticity and rigidity.
Hefferan MP; Fuchigami T; Marsala M
Neurosci Lett; 2006 Jul; 403(1-2):195-200. PubMed ID: 16716507
[TBL] [Abstract][Full Text] [Related]
6. Long-term intraventricular baclofen infusion in beagles.
Albright AL
J Neurosurg; 2007 Sep; 107(3 Suppl):225-7. PubMed ID: 17918530
[TBL] [Abstract][Full Text] [Related]
7. Favorable response to intrathecal, but not oral, baclofen of priapism in a patient with spinal cord injury.
D'Aleo G; Rifici C; Kofler M; Saltuari L; Bramanti P
Spine (Phila Pa 1976); 2009 Feb; 34(3):E127-9. PubMed ID: 19179913
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal baclofen for treatment of intractable spinal spasticity.
Abel NA; Smith RA
Arch Phys Med Rehabil; 1994 Jan; 75(1):54-8. PubMed ID: 8291963
[TBL] [Abstract][Full Text] [Related]
9. Chronic subarachnoid administration of 1-(4chlorobenzoyl)-5methoxy-2methyl-1H-indole-3 acetic acid (indomethacin): an evaluation of its neurotoxic effects in an animal model.
Guevara-López U; Covarrubias-Gómez A; Gutierrez-Acar H; Aldrete JA; López-Muñoz FJ; Martínez-Benítez B
Anesth Analg; 2006 Jul; 103(1):99-102, table of contents. PubMed ID: 16790634
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid baclofen concentrations in patients undergoing continuous intrathecal baclofen therapy.
Albright AL; Thompson K; Carlos S; Minnigh MB
Dev Med Child Neurol; 2007 Jun; 49(6):423-5. PubMed ID: 17518926
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and safety studies on intrathecally infused recombinant-methionyl human brain-derived neurotrophic factor in dogs.
Yaksh TL; Rathbun ML; Dragani JC; Malkmus S; Bourdeau AR; Richter P; Powell H; Myers RR; Lebel CP
Fundam Appl Toxicol; 1997 Jul; 38(1):89-100. PubMed ID: 9268608
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory mass of an intrathecal catheter in patients receiving baclofen as a sole agent: a report of two cases and a review of the identification and treatment of the complication.
Deer TR; Raso LJ; Garten TG
Pain Med; 2007 Apr; 8(3):259-62. PubMed ID: 17371413
[TBL] [Abstract][Full Text] [Related]
13. Functional outcome of intrathecal baclofen administration for severe spasticity.
Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
[TBL] [Abstract][Full Text] [Related]
14. Preclinical toxicity screening of intrathecal adenosine in rats and dogs.
Chiari A; Yaksh TL; Myers RR; Provencher J; Moore L; Lee CS; Eisenach JC
Anesthesiology; 1999 Sep; 91(3):824-32. PubMed ID: 10485794
[TBL] [Abstract][Full Text] [Related]
15. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
[TBL] [Abstract][Full Text] [Related]
16. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
[TBL] [Abstract][Full Text] [Related]
17. [Antinociceptive effects of intrathecally administered GABA agonists at the spinal cord level].
Yamada Y; Saito Y; Hara K; Kirihara Y; Doi K; Kosaka Y
Masui; 1999 Jun; 48(6):605-10. PubMed ID: 10402811
[TBL] [Abstract][Full Text] [Related]
18. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; Pittalà G; Castiglione A; Patti F; Mangiameli S
Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
[TBL] [Abstract][Full Text] [Related]
19. Limitations of intrathecal baclofen for spastic hemiparesis following stroke.
Kofler M; Quirbach E; Schauer R; Singer M; Saltuari L
Neurorehabil Neural Repair; 2009 Jan; 23(1):26-31. PubMed ID: 18796543
[TBL] [Abstract][Full Text] [Related]
20. [Intrathecal baclofen for severe spasticity].
Ueta T
Brain Nerve; 2008 Dec; 60(12):1415-20. PubMed ID: 19110752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
